States and federal government try new tactics on opioid regulation
This article was originally published in Scrip
Executive Summary
In the US, companies, federal agencies and individual states are engaged in a struggle to curb opioid misuse without curbing sales to patients who need them. This will be one of the biggest tasks for regulators in 2011, writes Daniel B Moskowitz.